GlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.
Use this information to figure out if this company is an ideal customer for you.
801.649.3999
675 Arapeen Drive
Salt Lake City, 84108
11 - 50 Employees
$1M - $5M
linkedin.com/company/glycomira-llc
The most common GlycoMira Therapeutics Inc. email format is [last].[first] (ex. doe.john@glycomira.com), currently being used by 100% of GlycoMira Therapeutics Inc. business email addresses. There are 2 email formats used by GlycoMira Therapeutics Inc..
GlycoMira Therapeutics Inc.'s CEO is William P Tew
GlycoMira Therapeutics Inc.'s CFO is Tom Heath
GlycoMira Therapeutics Inc.'s HQ is located at 675 Arapeen Drive, Salt Lake City
GlycoMira Therapeutics Inc.'s phone number is 801.649.3999
GlycoMira Therapeutics Inc.'s official website is glycomira.com
GlycoMira Therapeutics Inc.'s revenue is $1M - $5M
GlycoMira Therapeutics Inc. has 11 - 50 employees
GlycoMira Therapeutics Inc. is in the industry of: Pharmaceuticals
